Search research articles
Contact Us
Filters
Showing results (251-260 of 294) with videos related to
Page
of 30
Sort By:
Cancer Research Communications
|
April 8, 2022
Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade Glioma
Lucas A Salas, Thomas G Stewart, Bret C Mobley, et al.
Elife
|
June 24, 2020
Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells
Nalin Leelatian, Justine Sinnaeve, Akshitkumar M Mistry, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
Amyloid-β-regulated gene circuits for programmable Alzheimer's disease therapy
Madeline R Spetz, Hyosung Kim, Daniel Chavarria, et al.
JCI Insight
|
May 16, 2023
An immunosuppressed microenvironment distinguishes lateral ventricle-contacting glioblastomas
Todd Bartkowiak, Sierra M Lima, Madeline J Hayes, et al.
Acta Neuropathologica Communications
|
November 6, 2019
BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease
J Picarsic, T Pysher, H Zhou, et al.
Bioorganic & Medicinal Chemistry
|
October 2, 2020
Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators
Kevin D Rynearson, Ronald N Buckle, R Jason Herr, et al.
Trends in Biotechnology
|
January 26, 2020
Enabling Technologies for Personalized and Precision Medicine
Dean Ho, Stephen R Quake, Edward R B McCabe, et al.
Brain Research
|
October 12, 2010
Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice
Tao Yu, Chunhong Liu, Pavel Belichenko, et al.
Neurobiology of Disease
|
October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]
H M Mitchison, D J Bernard, N D Greene, et al.
Acta Neuropathologica Communications
|
March 17, 2019
Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis
Norman L Lehman, Aisulu Usubalieva, Tong Lin, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 294) with videos related to
Sort By:
Page
of 30
Cancer Research Communications
|
April 8, 2022
Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade Glioma
Lucas A Salas, Thomas G Stewart, Bret C Mobley, et al.
Elife
|
June 24, 2020
Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells
Nalin Leelatian, Justine Sinnaeve, Akshitkumar M Mistry, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
Amyloid-β-regulated gene circuits for programmable Alzheimer's disease therapy
Madeline R Spetz, Hyosung Kim, Daniel Chavarria, et al.
JCI Insight
|
May 16, 2023
An immunosuppressed microenvironment distinguishes lateral ventricle-contacting glioblastomas
Todd Bartkowiak, Sierra M Lima, Madeline J Hayes, et al.
Acta Neuropathologica Communications
|
November 6, 2019
BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease
J Picarsic, T Pysher, H Zhou, et al.
Bioorganic & Medicinal Chemistry
|
October 2, 2020
Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators
Kevin D Rynearson, Ronald N Buckle, R Jason Herr, et al.
Trends in Biotechnology
|
January 26, 2020
Enabling Technologies for Personalized and Precision Medicine
Dean Ho, Stephen R Quake, Edward R B McCabe, et al.
Brain Research
|
October 12, 2010
Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice
Tao Yu, Chunhong Liu, Pavel Belichenko, et al.
Neurobiology of Disease
|
October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]
H M Mitchison, D J Bernard, N D Greene, et al.
Acta Neuropathologica Communications
|
March 17, 2019
Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis
Norman L Lehman, Aisulu Usubalieva, Tong Lin, et al.
Page
of 30